Drug Type Small molecule drug |
Synonyms LUF7602 |
Target |
Mechanism A3R antagonists(Adenosine A3 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC23H24FN5O6S |
InChIKeyQNCALQNHCSHYFR-UHFFFAOYSA-N |
CAS Registry2303983-66-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | NL | 02 Aug 2023 |